Brief: Matinas Biopharma Resumes Enrollment In The Enhance-It And Enact Clinical Trials

Matinas BioPharma Holdings

30/06/2020 22:15

June 30 (Reuters) - Matinas BioPharma Holdings Inc  MTNB.A :
    * MATINAS BIOPHARMA RESUMES ENROLLMENT IN THE ENHANCE-IT AND
ENACT
CLINICAL TRIALS
    * MATINAS BIOPHARMA - TOPLINE DATA FROM ENHANCE-IT STUDY OF
MAT9001 VERSUS. VASCEPA EXPECTED IN Q1 2021
    * MATINAS BIOPHARMA - ENACT REMAINS ON TRACK FOR COHORT
PROGRESSION IN Q4 2020
    * MATINAS BIOPHARMA - EXPECTS TO COMPLETE ENROLLMENT IN
ENHANCE-IT
STUDY IN AUGUST OF 2020

Source text for Eikon:  ID:nGNX1nLnWP 
Further company coverage:  MTNB.A 

 (Reuters.Briefs@thomsonreuters.com)